Literature DB >> 31587268

Mucosal-associated invariant T cells and Vδ2+ γδ T cells in community acquired pneumonia: association of abundance in sputum with clinical severity and outcome.

R F Hannaway1, X Wang1, M Schneider1, S Slow2, J Cowan3, B Brockway3, M R Schofield4, X C Morgan1, D R Murdoch2, J E Ussher1.   

Abstract

Mucosal-associated invariant T (MAIT) cells and Vδ2+ γδ T cells are anti-bacterial innate-like lymphocytes (ILLs) that are enriched in blood and mucosa. ILLs have been implicated in control of infection. However, the role of ILLs in community-acquired pneumonia (CAP) is unknown. Using sputum samples from a well-characterized CAP cohort, MAIT cell and Vδ2+ T cell abundance was determined by quantitative polymerase chain reaction (qPCR). Cytokine and chemokine concentrations in sputum were measured. The capacity of bacteria in sputum to produce activating ligands for MAIT cells and Vδ2+ T cells was inferred by 16S rRNA sequencing. MAIT cell abundance in sputum was higher in patients with less severe pneumonia; duration of hospital admission was inversely correlated with both MAIT and Vδ2+ T cell abundance. The abundance of both ILLs was higher in patients with a confirmed bacterial aetiology; however, there was no correlation with total bacterial load or the predicted capacity of bacteria to produce activating ligands. Sputum MAIT cell abundance was associated with interferon (IFN)-α, IFN-γ, and sputum neutrophil abundance, while Vδ2+ T cell abundance was associated with CXCL11 and IFN-γ. Therefore, MAIT and Vδ2+ T cells can be detected in sputum in CAP, where they may contribute to improved clinical outcome.
© 2019 British Society for Immunology.

Entities:  

Keywords:  MAIT cells; Vδ2+ T cells; community-acquired pneumonia; gamma delta T cells; qPCR; severity

Mesh:

Substances:

Year:  2019        PMID: 31587268      PMCID: PMC6954682          DOI: 10.1111/cei.13377

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  65 in total

1.  Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults.

Authors:  Seema Jain; Wesley H Self; Richard G Wunderink; Sherene Fakhran; Robert Balk; Anna M Bramley; Carrie Reed; Carlos G Grijalva; Evan J Anderson; D Mark Courtney; James D Chappell; Chao Qi; Eric M Hart; Frank Carroll; Christopher Trabue; Helen K Donnelly; Derek J Williams; Yuwei Zhu; Sandra R Arnold; Krow Ampofo; Grant W Waterer; Min Levine; Stephen Lindstrom; Jonas M Winchell; Jacqueline M Katz; Dean Erdman; Eileen Schneider; Lauri A Hicks; Jonathan A McCullers; Andrew T Pavia; Kathryn M Edwards; Lyn Finelli
Journal:  N Engl J Med       Date:  2015-07-14       Impact factor: 91.245

2.  IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection.

Authors:  Euan Lockhart; Angela M Green; JoAnne L Flynn
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

3.  CD8+ T cells and risk for bacterial pneumonia and all-cause mortality among HIV-infected women.

Authors:  Shruti K Gohil; Moonseong Heo; Ellie E Schoenbaum; David Celentano; Liise-anne Pirofski
Journal:  J Acquir Immune Defic Syndr       Date:  2012-06-01       Impact factor: 3.731

4.  Comparison of inflammatory cell counts in asthma: induced sputum vs bronchoalveolar lavage and bronchial biopsies.

Authors:  D C Grootendorst; J K Sont; L N Willems; J C Kluin-Nelemans; J H Van Krieken; M Veselic-Charvat; P J Sterk
Journal:  Clin Exp Allergy       Date:  1997-07       Impact factor: 5.018

5.  T helper 17 cells are involved in the local and systemic inflammatory response in community-acquired pneumonia.

Authors:  Marthe S Paats; Ingrid M Bergen; Wessel E J J Hanselaar; E Christine Groeninx van Zoelen; Henry A Verbrugh; Henk C Hoogsteden; Bernt van den Blink; Rudi W Hendriks; Menno M van der Eerden
Journal:  Thorax       Date:  2013-01-12       Impact factor: 9.139

6.  Predictors for length of hospital stay in patients with community-acquired pneumonia: results from a Swiss multicenter study.

Authors:  Isabelle Suter-Widmer; Mirjam Christ-Crain; Werner Zimmerli; Werner Albrich; Beat Mueller; Philipp Schuetz
Journal:  BMC Pulm Med       Date:  2012-05-20       Impact factor: 3.317

7.  MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets.

Authors:  A Kurioka; J E Ussher; C Cosgrove; C Clough; J R Fergusson; K Smith; Y-H Kang; L J Walker; T H Hansen; C B Willberg; P Klenerman
Journal:  Mucosal Immunol       Date:  2014-10-01       Impact factor: 7.313

8.  Th17 cells are associated with protection from ventilator associated pneumonia.

Authors:  Marika Orlov; Victoria Dmyterko; Mark M Wurfel; Carmen Mikacenic
Journal:  PLoS One       Date:  2017-08-14       Impact factor: 3.240

9.  Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data.

Authors:  J M Ruijter; C Ramakers; W M H Hoogaars; Y Karlen; O Bakker; M J B van den Hoff; A F M Moorman
Journal:  Nucleic Acids Res       Date:  2009-02-22       Impact factor: 16.971

10.  Molecular Analyses Define Vα7.2-Jα33+ MAIT Cell Depletion in HIV Infection: A Case-Control Study.

Authors:  James E Ussher; Prabhjeet Phalora; Cormac Cosgrove; Rachel F Hannaway; Andri Rauch; Huldrych F Günthard; Philip Goulder; Rodney E Phillips; Christian B Willberg; Paul Klenerman
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.817

View more
  4 in total

Review 1.  Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer's Disease.

Authors:  Tamas Fulop; Shreyansh Tripathi; Serafim Rodrigues; Mathieu Desroches; Ton Bunt; Arnold Eiser; Francois Bernier; Pascale B Beauregard; Annelise E Barron; Abdelouahed Khalil; Adam Plotka; Katsuiku Hirokawa; Anis Larbi; Christian Bocti; Benoit Laurent; Eric H Frost; Jacek M Witkowski
Journal:  Neuropsychiatr Dis Treat       Date:  2021-05-04       Impact factor: 2.570

Review 2.  Title of article: Mucosal-associated invariant T cells in lung diseases.

Authors:  Xue Wen; Xingli Zhang; Siji Nian; Gang Wei; Xiyuan Guo; Hong Yu; Xiang Xie; Yingchun Ye; Qing Yuan
Journal:  Int Immunopharmacol       Date:  2021-02-26       Impact factor: 4.932

3.  Activation and Functional Alteration of Mucosal-Associated Invariant T Cells in Adult Patients With Community-Acquired Pneumonia.

Authors:  Lichen Ouyang; Mi Wu; Zhijun Shen; Xue Cheng; Wei Wang; Lang Jiang; Juan Zhao; Yeli Gong; Zhihui Liang; Xiufang Weng; Muqing Yu; Xiongwen Wu
Journal:  Front Immunol       Date:  2021-12-21       Impact factor: 7.561

Review 4.  Frontline workers: Mediators of mucosal immunity in community acquired pneumonia and COVID-19.

Authors:  Priyanka S Hastak; Christopher R Andersen; Anthony D Kelleher; Sarah C Sasson
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.